The Pharmacist Write Resources Hub

Categories

Categories
  • All
  • Managed Care Pharmacy (29)
  • GLP1 Hub (26)
  • Technology and AI in Pharmacy (25)
  • Patient Education and Medication Management (22)
  • Essays (16)
  • Opinion (9)
  • Healthcare Navigation and Insurance Literacy (5)
  • Trading (3)
  • Aisembly (2)
  • Biotech or Brick Series (1)
  • Future of Pharmacy (1)
  • P3S (1)
GLP‑1 Coverage & Prior Authorization Checklist (Full 2025 Guide)
Part 9: Bonus — Underwriting Transparent Drug Coverage
Part 8: The Fall of Rebates and the Rise of NodeID — Toward Transparent, Fixed-Gain Drug Access
Sunset Strategy: How Amgen’s Repatha Shows the Future of Late-Stage Asset Pharma Pricing
On Attention
Strensiq: An End‑to‑End FWA Risk Scenario
How Pharmacy Payers Change Policy: A Process Overview
ACC/AHA’s 2025 Guideline Playbook: How to Build Care—and Tools—That Earn Trust
On Exploitation
From Chaos to Counsel: A Framework for Facilitative Promotion
Alternative Careers for Pharmacists: Expand Your Path
Covered Calls: Building Your First Income Stream
What a Simple Drug Prior Authorization Policy Looks Like
From Extraction to Circulation: The Future of Billing Is Cooperative
Fear Is Not the Foe: Notes on Perceptual Pressure and the Soft Science of Sovereignty
The Platform Is the Train: How Algorithmic Anesthesia Is Rewiring Our Will
The Goodness Arbitrage Protocol (GAP): An Ethical Framework for Reflective Creation
Reflective Intelligence 101: How to Move from Resonance to Compellence with Calm, Clarity, and Conviction
Designing a Value-Based Formulary in 10 Steps
Switching from Semaglutide to Tirzepatide Dose Conversion Best Practices
How Long Can You Stay on Semaglutide for Weight Loss
Zepbound vs Semaglutide Safety Efficacy Coverage
Zepbound vs Mounjaro Which Is Better for Weight Loss
Is Zepbound the Same as Tirzepatide Understanding Brands and Generics
Zepbound vs Ozempic Key Differences for Weight Loss
How I Produced 100+ SEO/AIO-Optimized Articles Combining AI and Pharmacy Expertise
The P3S Framework: A Virtuous Cycle for Career Growth and Reflective Leadership
Pharmacy Benefit Management Consulting: What You Need to Know
Wegovy 1 Month Results: Setting Realistic Expectations
Does Wegovy Give You Energy? Separating Fact from Fiction
Knockout Gene-Inspired Prior Authorization Logic
How Pharmacy Benefit Analytics Improves Plan Efficiency & Cost Management
Tackling Wegovy Fatigue: Why It Happens & How to Cope
Drug Utilization Management 101: Rules, Tools & Best Practices
Unedited & Unfiltered: An Experience with Zepbound on a Weight Loss Journey
Wegovy Maintenance Dose After Goal Weight: What Patients Need to Know
At What Dose Does Wegovy Start Working? A Pharmacist’s Perspective
Semaglutide vs. Tirzepatide: Mechanisms, Differences, & Outcomes
Understanding GLP 1 & GLP1/GIP: The Superior Drug Class in Weight Management
Part 7: Gradual Governance Transfer – Shifting from Centralized PBMs to a Distributed, Multi-Stakeholder Model
Part 6: Applying Elinor Ostrom’s Framework – How Institutional Diversity Shapes Drug Coverage Node Enumeration
Part 5: Drug-Coverage Node Enumeration: Real-World Applications, Pilot Opportunities, and Future Outlook
Part 4: Building an Open Infrastructure for Node-Based Drug Coverage
Part 3: Building the Exhaustive Parameter Library: Enumerating All Coverage Options
Part 2: Introducing Enumerated Node-Based Drug Coverage: Redefining the Manufacturer–Payer Interface in Pharmacy Benefits
Part 1: The Origins of Drug Coverage Centralization – Why a New Model Is Needed
An Insurer-Less Pharmacy Ecosystem?
From P&T Committee to Exchange Forum: The Evolution of Drug Coverage Decision-Making
Reimagining The Claims Processing Partnership Structure: How Outsourcing Powers a Next-Gen PBM Alternative
Transparent Admin Fee vs. Spread Pricing: A Better Revenue Model for Pharmacy Services